Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ·Healthcare·Biotechnology
$35.42
+1.23%
Mkt Cap $3.54B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (21 analysts)
$86.60
Range $67.00 – $105.00
Implied Upside
+144.5%
Consensus $86.60 vs current $35.42